AstraZeneca acquries Almirall Drugs for $2.1 Billion

AstraZeneca acquries Almirall Drugs for $2.1 Billion

AstraZeneca acquries Almirall Drugs for $2.1 Billion

The UK drugmaker AstraZeneca , after failed Pfizer Inc. takeover attempt, buys Almirall Drugs for $2.1 Billion.

“Our agreement with Almirall brings strategic and long-term value to AstraZeneca’s strong respiratory franchise, one of our key growth platforms,” said Pascal Soriot, CEO of AstraZeneca.

AstraZeneca will make additional payments – $875 million for drugs including Eklira, as much as $1.22 billion if the drugs meet development and sales goals, the London-based company said in a statement today. Almirall, based in Barcelona, also will transfer its Sofotec device unit to AstraZeneca.

One of parts of the deal, AstraZeneca will acquire Eklira, also called Tudorza Pressair, a for smoking-related diseases such as bronchitis and emphysema, which recorded 84 million euros ($112 million) in sales in 2013 and made up 12 percent of Almirall’s revenue.

Mr. Stakebay says:

This deal will approve AstraZeneca’s earnings next year and add to them in 2016. This deal came after unsuccessful bid from side of Pfizer to buy Astrazeneca for $117 Billion in May. U.S. regulatory bureaus asked for additional data, although is approved in Europe.

CEO of AstraZeneca…………………………….Pascal Soriot ……………………………. (2012-present)……………………………..$ 5 748 018

CEO of Almirall ………………………… Eduardo Javier Sanchiz Yrazu………………. (2011-present)

 

ASTRAZENECA

ALMIRALL

Revenue

$ 25.71 Billion(2013)

€ 825 .5 Million(2013)

Operating income

$ 3.71 Billion(2013)

€ 67.1 Million (2013)

Profit

$ 2.57 Billion(2013)

– 33.7 Million(2013)

Total assets

$ 55.899 Billion (2013)

€   1.772 Billion(2013)

Total Equity

$ 23. 253 Billion (2013)

€ 888.3 Million(2013)

Employees

51500 (2013)

3000 (2013)

You Might Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>